Fetching from the wire…
01
02
03
04
05
06
07
08
Markets2026-08-30 · source-backed
After more than a decade growing a16z's bio and health practice to nearly $4 billion, Pande started VZVC with Zach Werner. The investment team is the two of them with no associates, leaning on AI agents for day-to-day operations, targeting roughly five concentrated investments a year instead of thirty. (TechCrunch) His thesis is that the binding constraint in AI biotech is high-quality biological data, which unlike text or images can't be scraped, so VZVC targets companies building proprietary datasets and foundation models on top of them.
Each link below shares sources, entities, or timing with this story.
Shared entity: TechCrunch / Same source domain / Shared topic / Earlier coverage
Both cover TechCrunch; reported by the same outlet (techcrunch.com); overlapping topics (billion, company, concentrated, data).
Shared entity: TechCrunch / Same source domain / Shared topic / Earlier coverage / Tension
Both cover TechCrunch; reported by the same outlet (techcrunch.com); overlapping topics (company, data).
Both cover TechCrunch; reported by the same outlet (techcrunch.com); overlapping topics (agent, billion).
Shared entity: TechCrunch / Same source domain / Shared topic / Earlier coverage
Both cover TechCrunch; reported by the same outlet (techcrunch.com); overlapping topics (company, constraint, data).
Shared entity: TechCrunch / Same source domain / Earlier coverage / Tension / Downstream implication
Both cover TechCrunch; reported by the same outlet (techcrunch.com); earlier TechCrunch coverage from 2026-03-10.
Shared entity: TechCrunch / Same source domain / Shared topic / Earlier coverage
Both cover TechCrunch; reported by the same outlet (techcrunch.com); overlapping topics (a16z, data).
Both cover TechCrunch; reported by the same outlet (techcrunch.com); overlapping topics (agent, data).
Both cover TechCrunch; reported by the same outlet (techcrunch.com); overlapping topics (agent, company).